Insider Transactions in Q2 2021 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2021
|
Elizabeth A. Barrett Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,425
-0.71%
|
$58,225
$17.51 P/Share
|
|
May 17
2021
|
Jason Drew Smith General Counsel |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$37,500
$15.71 P/Share
|
|
May 17
2021
|
Molly Henderson Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$37,500
$15.85 P/Share
|
|
Apr 30
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
243
-1.14%
|
$4,860
$20.0 P/Share
|
|
Apr 30
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.29%
|
-
|
|
Apr 26
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
89
-0.42%
|
$1,691
$19.63 P/Share
|
|
Apr 26
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+0.99%
|
-
|